EquityInvest.com Raises $128,450 for SerOptix, Inc.

BOSTON, MA – February 19, 2002 - EquityInvest.com, a web’s leading company, specializing in assisting private companies in need of venture capital to expand their businesses, has raised $128,450 from angel investors in the past three weeks to help SerOptix’s new funding round of $7,500,000. Angel investors agreed to purchase Series C Convertible Preferred Stock of SerOptix, Inc. ("the company") at a purchase price of $1.50 per Share (the “Offering Price”). SerOptix, Inc. is a pioneer in healthcare and biopharmaceutical applications of spectra-molecular informatics.

"This is just the beginning of our new raise for SerOptix, Inc., with commitments for substantially more as the opportunities to find new angel investors arise. This year, we are excited to have Mr. Michael Lu, helping our team. He has a great track record for raising money for private companies, as he (1) closed multimillion-dollar US and international sales transactions (PDF File), (2) created profitable operations for many years, and (3) directly invested and raised more than $70 million investment capital for existing and new enterprises," Milo Georgiev, Chairman and CEO of EquityInvest.com, said. "We helped the company in its prior funding round: Since the affiliation with SerOptix, Inc., EquityInvest.com team and its business associates were able to locate angel investors who invested close to $1,700,000 in the SerOptix's Series C Convertible Preferred Stock. We feel that the company has a business model and agenda that will work in this particular economic climate, and we will continue to provide the capital which will help SerOptix, Inc. to execute its overall strategic business plan," stated Milo.

In August 23, 2001, EquityInvest.com has announced a key relationship with SerOptix, Inc. as signing new business agreement. Under terms of the agreement, EquityInvest.com’s responsibility include optimizing a marketing plan, sharing business development ideas, assisting in securing a corporate partner, introducing individual and institutional investors to the company.

Important Factors Relating to Forward-Looking Statements

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements so long as those statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materially from those projected in such statements. All statements, including words such as "anticipate," "believe," "plan," "estimate," "expect," "intend" and other similar expressions, constitute forward-looking statements under the Private Securities Litigation Reform Act of 1995. In connection with certain forward-looking statements contained in this press release and those that may be made in the future by or on behalf of EquityInvest.com, our company’s representatives note that there are various factors that could cause actual results to differ materially from those set forth in any such forward-looking statements. The forward-looking statements contained in this press release were prepared by management and are qualified by, and subject to, significant business, economic, competitive, regulatory and other uncertainties and contingencies, all of which are difficult or impossible to predict and many of which are beyond the control of EquityInvest.com. Accordingly, there can be no assurance that the forward-looking statements contained in this press release will be realized or that actual results will not be significantly higher or lower. Readers of this press release should consider these facts in evaluating the information contained herein. In addition, the business and operations of the EquityInvest.com are subject to substantial risks, which increase the uncertainty inherent in the forward-looking statements contained in this press release. The inclusion of the forward-looking statements contained in this press release should not be regarded as a representation by EquityInvest.com or any other person that the forward-looking statements contained in the press release will be achieved. In light of the foregoing, readers of this press release are cautioned not to place undue reliance on the forward-looking statements contained herein.